SEC Form 4 · accession 0001445064-15-000170
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Trudeau
Officer — President & CEO · Director
Period of report
Dec 3, 2015
Accepted (ET)
Dec 4, 2015 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Dec 3, 2015 | F | 2,073 | $72.20 | D | 165,453 | D |
Table II — derivative securities
No Table II lines on this filing.